Pharmacy PEBC Practice Exam Flash Cards

An adequately powered, randomized controlled trial conducted over 2 years demonstrated that the primary outcome (a serious cardiovascular event) occurred in 15% of the patients who received the new drug, whereas the primary outcome occurred in 25% of the patients who received a placebo. The relative risk reduction achieved with the new drug is: